Cellectis S.A. ADR (CLLS)

$2.06 0.03 (1.48%)

14:30 EDT CLLS Stock Quote Delayed 30 Minutes

InvestorPlace Earnings

CLLS Stock Earnings: Cellectis Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 28, 2024

CLLS stock results show that Cellectis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

CLLS Stock Earnings: Cellectis Misses EPS, Misses Revenue for Q4 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Why Is Cellectis (CLLS) Stock Up 175% Today?

More Articles

Volume:

Previous Close -

Market Cap 93.70M

PE Ratio -

EPS -

Volume (Avg. Vol.) 8,850

Day's Range $2.04 - $2.09

52-Week Range $0.96 - $3.77

Dividend & Yield N/A (N/A)

CLLS Stock Predictions, Articles, and Cellectis S.A. ADR News

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 1, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today!

7 CRISPR Stocks With the Best Long-Term Potential

By Alex Sirois, InvestorPlace Contributor Jan 30, 2023

CRISPR stocks are becoming commercially viable leading to substantial returns in 2023 and beyond, as the technology will only improve.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jan 11, 2022

Grab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday!

7 Gene Editing Stocks Promising to Change our DNA

By Chris Markoch, InvestorPlace Contributor Sep 15, 2021

Gene editing stocks will take off as the underlying tech moves from fiction to fact and companies put their products on the market.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jul 12, 2021

Welcome back, trader! We're kicking off the week with a look at the biggest pre-market stock movers you need to know about for Monday!

Investing in CRISPR Stocks: Ultimate Genetic Editing Guide

By Luke Lango, InvestorPlace Senior Investment Analyst Jul 5, 2021

The biotech space is on the verge of hypergrowth, thanks to a scientific breakthrough in genetic editing. This is your ultimate guide to understanding and profiting from CRISPR stocks.

The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century

By Luke Lango, InvestorPlace Senior Investment Analyst Jul 1, 2021

Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy.

7 CRISPR Stocks for the Future of Medicine

By Luke Lango, InvestorPlace Senior Investment Analyst Jan 15, 2021

Between these seven genetic editing pioneers, you have the widest exposure to the biggest scientific breakthrough of the century.

ADVERTISEMENT